In a nutshell This study evaluated the safety and effectiveness of brentuximab vedotin (Adcetris) plus chemotherapy for patients with advanced (stage 3 – 4) Hodgkin’s lymphoma (HL). This study concluded that this treatment is effective for these patients. Some background The most commonly used frontline chemotherapy regimen for advanced HL...
Read MoreCurrent treatment status-Did not start treatment yet Posts on Medivizor
Reviewing treatment strategies for early-stage Hodgkin lymphoma
In a nutshell This article reviews treatment strategies for patients with early-stage (stage 1 – 2) Hodgkin lymphoma (HL). Some background One of the main treatment goals for patients with HL is to improve long-term outcomes. However, many patients experience complications decades after initial treatment. These may include secondary cancer...
Read MoreRisk of hepatitis B reactivation in patients with lymphomas receiving obinutuzumab or rituximab
In a nutshell This study looked at the risk of reactivating hepatitis B (HBV) infection in patients with lymphoma treated with obinutuzumab (Gazyva) or rituximab (Rituxan). Researchers found that HBV infection was reactivated in some of these patients but treatment options are available. Some background Lymphoma is a cancer of the immune system....
Read MoreLenalidomide and dexamethasone in the treatment of chronic lymphocytic leukemia
In a nutshell The study looked at the safety and effectiveness of adding dexamethasone (Decadron) to lenalidomide (Revlimid) in previously untreated patients with chronic lymphocytic leukemia (CLL). Researchers concluded that lenalidomide plus dexamethasone is an effective treatment for CLL. Some background Chronic lymphocytic leukemia (CLL) is a...
Read MoreTiming of radiation therapy in patients with non-small cell lung cancer
In a nutshell This study wanted to find out how the timing of radiation therapy affected survival in patients with lung cancer who underwent surgery. The study found that there was no difference in survival based on timing of radiation therapy. Some background There are a number of options for treatment of non-small cell lung cancer. Surgery...
Read MoreEvaluating the use of PET scanning after first-line treatment for follicular lymphoma
In a nutshell This study evaluated the value of PET (positron emission tomography) scanning after first-line (primary) chemoimmunotherapy in patients with previously untreated follicular lymphoma (FL). This study concluded that PET scanning is a better imaging technique than CT (computed tomography) for assessing treatment response in these...
Read MoreScalp cooling to prevent hair loss in patients with breast cancer
In a nutshell This study wanted to see if using a scalp cooling cap during chemotherapy stopped patients with breast cancer from losing their hair. The study found that scalp cooling help prevent the patients from losing their hair. Some background An unfortunate side effect of chemotherapy for breast cancer is that often, patients lose their hair. It...
Read MoreEvaluating rituximab maintenance therapy for elderly patients with follicular lymphoma
In a nutshell This study evaluated the effectiveness of maintenance therapy with rituximab (Rituxan) in elderly patients with newly diagnosed follicular lymphoma (FL). This study concluded that maintenance rituximab treatment improved survival outcomes in these patients in a real-world setting. Some background Chemoimmunotherapy containing rituximab...
Read MoreComparing prostate surgery with radiotherapy and radiotherapy with androgen deprivation therapy for advanced prostate cancer
In a nutshell This study aimed to investigate the long-term effects of two treatment combinations for advanced prostate cancer. This study found that surgery and radiotherapy had improved overall survival in comparison with radiotherapy plus androgen deprivation therapy (ADT) in these patients, but with higher rates of side-effects. Some background...
Read MoreEvaluating short-course ABVD chemotherapy in patients with early-stage Hodgkin lymphoma
In a nutshell This study evaluated the effectiveness of short-course (2 cycles) ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy with interim PET scanning in previously untreated patients with early-stage (stage 1 – 2) Hodgkin’s lymphoma (HL). This study concluded that short-course ABVD was effective in the majority of...
Read More2018 Guidelines for the treatment of Early Stage Prostate Cancer
In a nutshell This article reviewed treatment guidelines that have been recommended for patients with early-stage prostate cancer. Some background This analysis of existing treatment guidelines was done by the leading experts in prostate cancer research. They have made recommendations on the treatment of early-stage prostate cancer. Methods...
Read MoreSequential treatment for patients with chronic lymphocytic leukemia who have received bendamustine
In a nutshell This study aimed to investigate the effectiveness of obinutuzumab and venetoclax after bendamustine treatment in patients with chronic lymphocytic leukemia (CLL). This study concluded that this sequence of treatment caused no unexpected side effects. It also concluded that the outcomes were comparable to established therapies for CLL. Some...
Read More
